SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 273 filers reported holding SEATTLE GENETICS INC in Q4 2016. The put-call ratio across all filers is 2.22 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $283,000 | +5.2% | 5,200 | 0.0% | 0.34% | +10.6% |
| Q2 2017 | $269,000 | -20.6% | 5,200 | -3.7% | 0.31% | -15.9% |
| Q1 2017 | $339,000 | +18.9% | 5,400 | 0.0% | 0.37% | +22.0% |
| Q4 2016 | $285,000 | -1.0% | 5,400 | 0.0% | 0.30% | +11.4% |
| Q3 2016 | $288,000 | +32.1% | 5,400 | 0.0% | 0.27% | +33.8% |
| Q2 2016 | $218,000 | -11.7% | 5,400 | -1.8% | 0.20% | +5.7% |
| Q4 2015 | $247,000 | +16.5% | 5,500 | 0.0% | 0.19% | +13.5% |
| Q3 2015 | $212,000 | -20.3% | 5,500 | 0.0% | 0.17% | -6.1% |
| Q2 2015 | $266,000 | -21.3% | 5,500 | -39.6% | 0.18% | 0.0% |
| Q3 2014 | $338,000 | -2.9% | 9,100 | 0.0% | 0.18% | +4.6% |
| Q2 2014 | $348,000 | +52.6% | 9,100 | +82.0% | 0.17% | +43.0% |
| Q1 2014 | $228,000 | -50.5% | 5,000 | -56.7% | 0.12% | -51.8% |
| Q4 2013 | $461,000 | -0.9% | 11,550 | +9.0% | 0.25% | -4.9% |
| Q3 2013 | $465,000 | +39.6% | 10,600 | 0.0% | 0.26% | +40.4% |
| Q2 2013 | $333,000 | – | 10,600 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 45,725,556 | $2,487,928,000 | 20.18% |
| Lagoda Investment Management, L.P. | 306,694 | $16,687,000 | 6.03% |
| NEXTHERA CAPITAL LP | 373,000 | $20,295,000 | 5.22% |
| Redmile Group, LLC | 1,843,733 | $100,318,000 | 4.95% |
| Matrix Capital Management Company, LP | 2,118,000 | $115,240,000 | 3.68% |
| Sio Capital Management, LLC | 100,000 | $5,441,000 | 2.82% |
| Opus Point Partners Management, LLC | 41,263 | $2,245,000 | 2.01% |
| Eventide Asset Management | 525,000 | $28,565,000 | 1.62% |
| EMORY UNIVERSITY | 35,982 | $1,958,000 | 1.55% |
| Everett Capital Advisors UK LLP | 191,500 | $10,420,000 | 1.54% |